Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology, and clinical potential

References

• GuoAMArbabASFalckJRActivation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferationJ Pharmacol Exp Ther20073211182717210799
   PubMed Web of Science ®Google Scholar
• StecDEGannonKPBeairdJSDrummondHA20-hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cellsCell Physiol Biochem2007191–412112817310106
   PubMedGoogle Scholar
• LinFRiosAFalckJRBelosludtsevYSchwartzmanML20-hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubuleAm J Physiol19952696 Pt 2F806F8168594874
   PubMed Web of Science ®Google Scholar
• O’DonnellVBMaskreyBTaylorG WEicosanoids: generation and detection in mammalian cellsMethods Mol Biol200946252319160658
   PubMedGoogle Scholar
• ImigJDEicosanoid regulation of the renal vasculatureAm J Physiol Renal Physiol20002796F965F98111097615
   PubMed Web of Science ®Google Scholar
• ChatziantoniouCArendshorstWJRenal vascular reactivity to vasodilator prostaglandins in genetically hypertensive ratsAm J Physiol19922621 Pt 2F124F1301733288
   PubMed Web of Science ®Google Scholar
• WangDDuBoisRNProstaglandins and cancerGut200655111512216118353
   PubMed Web of Science ®Google Scholar
• WangDDuBoisRNEicosanoids and cancerNat Rev Cancer201010318119320168319
   PubMed Web of Science ®Google Scholar
• RigasBGoldmanISLevineLAltered eicosanoid levels in human colon cancerJ Lab Clin Med199312255185238228569
   PubMed Web of Science ®Google Scholar
• WangDDuboisRNCyclooxygenase-2: a potential target in breast cancerSemin Oncol2004311 Suppl 3647315052544
   PubMed Web of Science ®Google Scholar
• McLemoreTLHubbardWCLitterstCLProfiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patientsCancer Res19884811314031473130187
   PubMed Web of Science ®Google Scholar
• SorokinACyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotypeCurr Pharm Des200410664765714965327
   PubMed Web of Science ®Google Scholar
• PatelVADunnMJSorokinARegulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2J Biol Chem200227741389153892012138126
   PubMed Web of Science ®Google Scholar
• MyungSJRerkoRMYanM15-hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesisProc Natl Acad Sci USA200610332120981210216880406
   PubMed Web of Science ®Google Scholar
• NakanishiMMontroseDCClarkPGenetic deletion of mPGES-1 suppresses intestinal tumorigenesisCancer Res20086893251325918451151
   PubMed Web of Science ®Google Scholar
• BuchananFGWangDBargiacchiFDuBoisRNProstaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptorJ Biol Chem200327837354513545712824187
   PubMed Web of Science ®Google Scholar
• PaiRSoreghanBSzaboILPavelkaMBaatarDTarnawskiASProstaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophyNat Med20028328929311875501
   PubMed Web of Science ®Google Scholar
• ShengHShaoJWashingtonMKDuBoisRNProstaglandin E2 increases growth and motility of colorectal carcinoma cellsJ Biol Chem200127621180751808111278548
   PubMed Web of Science ®Google Scholar
• WangDWangHShiQProstaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor deltaCancer Cell20046328529515380519
   PubMed Web of Science ®Google Scholar
• ShengHShaoJMorrowJDBeauchampRDDuBoisRNModulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cellsCancer Res19985823623669443418
   PubMed Web of Science ®Google Scholar
• PoligoneBBaldwinASPositive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandinsJ Biol Chem200127642386583866411509575
   PubMed Web of Science ®Google Scholar
• FosslienEReview: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesisAnn Clin Lab Sci200131432534811688844
   PubMed Web of Science ®Google Scholar
• GatelySThe contributions of cyclooxygenase-2 to tumor angiogenesisCancer Metastasis Rev2000191–2192711191059
   PubMed Web of Science ®Google Scholar
• TakakuKSonoshitaMSasakiNSuppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) geneJ Biol Chem200027544340133401610969066
   PubMed Web of Science ®Google Scholar
• TrompezinskiSPernetISchmittDViacJUV radiation and prostaglandin E2 up-regulate vascular endothelial growth factor (VEGF) in cultured human fibroblastsInflamm Res200150842242711556523
   PubMed Web of Science ®Google Scholar
• PaiRSzaboILSoreghanBAAtaySKawanakaHTarnawskiASPGE(2) stimulates VEGF expression in endothelial cells via ERK2/ JNK1 signaling pathwaysBiochem Biophys Res Commun2001286592392811527387
   PubMed Web of Science ®Google Scholar
• PradonoPTazawaRMaemondoMGene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growthCancer Res2002621636611782360
   PubMed Web of Science ®Google Scholar
• Il LeeSZuoXShureiqiI15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?Cancer Metastasis Rev2011303–448149122037943
   PubMed Web of Science ®Google Scholar
• GaoXGrignonDJChbihiTElevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancerUrology19954622272377624992
   PubMed Web of Science ®Google Scholar
• LarréSTranNFanCPGE2 and LTB4 tissue levels in benign and cancerous prostatesProstaglandins Other Lipid Mediat2008871–4141918577464
   PubMed Web of Science ®Google Scholar
• DreylingKWHoppeUPeskarBAMorgenrothKKozuschekWPeskarBMLeukotriene synthesis by human gastrointestinal tissuesBiochim Biophys Acta198687821841933019409
   PubMed Web of Science ®Google Scholar
• HennigRDingXZTongWG5-lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissueAm J Pathol2002161242142812163367
   PubMed Web of Science ®Google Scholar
• IharaAWadaKYonedaMFujisawaNTakahashiHNakajimaABlockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancerJ Pharmacol Sci20071031243217220595
   PubMed Web of Science ®Google Scholar
• KandouzMNieDPidgeonGPKrishnamoorthySMaddipatiKRHonnKVPlatelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cellsProstaglandins Other Lipid Mediat2003713–418920414518561
   PubMed Web of Science ®Google Scholar
• NieDKrishnamoorthySJinRMechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cellsJ Biol Chem200628127186011860916638750
   PubMed Web of Science ®Google Scholar
• McCabeNPSelmanSHJankunJVascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenaseProstate200666777978716482570
   PubMed Web of Science ®Google Scholar
• TangDGGrossiIMChenYQDiglioCAHonnKV12(S)-HETE promotes tumor-cell adhesion by increasing surface expression of alpha V beta 3 integrins on endothelial cellsInt J Cancer19935411021118478136
   PubMed Web of Science ®Google Scholar
• PanigrahyDKaipainenAGreeneERHuangSCytochrome P450-derived eicosanoids: the neglected pathway in cancerCancer Metastasis Rev201029472373520941528
   PubMed Web of Science ®Google Scholar
• RomanRJP-450 metabolites of arachidonic acid in the control of cardiovascular functionPhysiol Rev200282113118511773611
   PubMed Web of Science ®Google Scholar
• CapdevilaJHFalckJRHarrisRCCytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenaseJ Lipid Res200041216318110681399
   PubMed Web of Science ®Google Scholar
• WangDDuBoisRNMeasurement of eicosanoids in cancer tissuesMethods Enzymol2007433275017954227
   PubMed Web of Science ®Google Scholar
• PowellPKWolfIJinRLaskerJMMetabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11J Pharmacol Exp Ther19982853132713369618440
   PubMed Web of Science ®Google Scholar
• BellamineAWangYWatermanMRCharacterization of the CYP4A11 gene, a second CYP4A gene in humansArch Biochem Biophys2003409122122712464262
   PubMed Web of Science ®Google Scholar
• ChristmasPJonesJPPattenCJAlternative splicing determines the function of CYP4F3 by switching substrate specificityJ Biol Chem200127641381663817211461919
   PubMed Web of Science ®Google Scholar
• YuWChaiHLiYIncreased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancerToxicol Appl Pharmacol20122641738322841774
   PubMed Web of Science ®Google Scholar
• MullerDNSchmidtCBarbosa-SicardEMouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formationBiochem J2007403110911817112342
   PubMed Web of Science ®Google Scholar
• YamaguchiYKiritaSHasegawaHContribution of CYP4A8 to the formation of 20-hydroxyeicosatetraenoic acid from arachidonic acid in rat kidneyDrug Metab Pharmacokinet200217210911615618658
   PubMedGoogle Scholar
• NakagawaKHollaVRWeiYSalt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channelJ Clin Invest200611661696170216691295
   PubMed Web of Science ®Google Scholar
• EscalanteBSessaWCFalckJRYadagiriPSchwartzmanMLVasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenaseJ Pharmacol Exp Ther198924812292322492340
   PubMed Web of Science ®Google Scholar
• HarderDRNarayananJGebremedhinDPressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood fowAm J Physiol Heart Circ Physiol20113005H1557H156521257913
   PubMed Web of Science ®Google Scholar
• WilliamsJMSarkisALopezBRyanRPFlaschAKRomanRJElevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresisHypertension200749368769417210834
   PubMed Web of Science ®Google Scholar
• WilliamsJMMurphySBurkeMRomanRJ20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertensionJ Cardiovasc Pharmacol201056433634420930591
   PubMed Web of Science ®Google Scholar
• QuigleyRBaumMReddyKMGrienerJCFalckJREffects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transportAm J Physiol Renal Physiol20002786F949F95310836982
   PubMed Web of Science ®Google Scholar
• WangSMengFXuJGuYEffects of lipids on ENaC activity in cultured mouse cortical collecting duct cellsJ Membr Biol20092272778519122972
   PubMed Web of Science ®Google Scholar
• PavlovTSIlatovskayaDVLevchenkoVMattsonDLRomanRJStaruschenkoAEffects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC)Am J Physiol Renal Physiol20113013F672F68121697242
   PubMed Web of Science ®Google Scholar
• HoaglandKMFlaschAKRomanRJInhibitors of 20-HETE formation promote salt-sensitive hypertension in ratsHypertension200342466967312874093
   PubMedGoogle Scholar
• ChenLAckermanRGuoAM20-HETE in neovascularizationProstaglandins Other Lipid Mediat2012983–4636822227460
   PubMed Web of Science ®Google Scholar
• AmaralSLMaierKGSchippersDNRomanRJGreeneASCYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesisAm J Physiol Heart Circ Physiol20032845H1528H153512521947
   PubMed Web of Science ®Google Scholar
• RapisardaAMelilloGRole of the VEGF/VEGFR axis in cancer biology and therapyAdv Cancer Res201211423726722588059
   PubMed Web of Science ®Google Scholar
• IshizukaTChengJSinghH20-hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of infammatory cytokines in human endothelial cellsJ Pharmacol Exp Ther2008324110311017947496
   PubMed Web of Science ®Google Scholar
• ZengQHanYBaoY20-HETE increases NADPH oxidasederived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytesAm J Physiol Heart Circ Physiol20102994H1109H111720675568
   PubMed Web of Science ®Google Scholar
• AkbulutTRegnerKRRomanRJAvnerEDFalckJRParkF20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanismAm J Physiol Renal Physiol20092973F662F67019570883
   PubMed Web of Science ®Google Scholar
• AlexanianAMillerBRomanRJSorokinA20-HETE-producing enzymes are up-regulated in human cancersCancer Genomics Proteomics20129416316922798501
   PubMed Web of Science ®Google Scholar
• LaiGWuJLiuXZhaoY20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathwayMol Endocrinol201226111907191622918876
   PubMedGoogle Scholar
• GuoMRomanRJFenstermacherJD9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N′-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4AJ Pharmacol Exp Ther200631719710816352703
   PubMed Web of Science ®Google Scholar
• AlexanianARufanovaVAMillerBFlaschARomanRJSorokinADown-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growthAnticancer Res200929103819382419846914
   PubMed Web of Science ®Google Scholar
• MiyataNTaniguchiKSekiTHET0016, a potent and selective inhibitor of 20-HETE synthesizing enzymeBr J Pharmacol2001133332532911375247
   PubMed Web of Science ®Google Scholar
• SatoMIshiiTKobayashi-MatsunagaYDiscovery of a N′-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitorBioorg Med Chem Lett200111232993299511714595
   PubMed Web of Science ®Google Scholar
• YuMCambj-SapunarLKehlFEffects of a 20-HETE antagonist and agonists on cerebral vascular toneEur J Pharmacol2004486329730614985052
   PubMed Web of Science ®Google Scholar
• QinXKwansaHBucciERomanRJKoehlerRCRole of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobinJ Appl Physiol2006100133634216166237
   PubMed Web of Science ®Google Scholar
• StecDEGannonKPBeairdJSDrummondHA20-hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cellsCell Physiol Biochem2007191–412112817310106
   PubMedGoogle Scholar
• TunctanBKorkmazBBuharaliogluCKA 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated ratsShock200830332933518323740
   PubMed Web of Science ®Google Scholar
• RegnerKRZukAVan WhySKProtective effect of 20-HETE analogues in experimental renal ischemia reperfusion injuryKidney Int200975551151719052533
   PubMed Web of Science ®Google Scholar
• ParkFSweeneyWEJiaGRomanRJAvnerED20-HETE mediates proliferation of renal epithelial cells in polycystic kidney diseaseJ Am Soc Nephrol2008208101929193918596124
   PubMed Web of Science ®Google Scholar
• NithipatikomKIsbellMASeeWACampbellWBElevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseasesCancer Lett2006233221922515882928
   PubMed Web of Science ®Google Scholar
• JacobsVLValdesPAHickeyWFDe LeoJACurrent review of in vivo GBM rodent models: emphasis on the CNS-1 tumour modelASN Neuro201133e0006321740400
   PubMed Web of Science ®Google Scholar
• GuoMRomanRJFalckJREdwardsPAScicliAGHuman U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N′-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4AJ Pharmacol Exp Ther2005315252653316081682
   PubMed Web of Science ®Google Scholar
• ChenPGuoMWygleDInhibitors of cytochrome P450 4A suppress angiogenic responsesAm J Pathol2005166261562415681843
   PubMed Web of Science ®Google Scholar
• GuoAMShengJScicliGMExpression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivoJ Pharmacol Exp Ther20083271101918591218
   PubMed Web of Science ®Google Scholar
• YuWChenLYangYQCytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancerCancer Chemother Pharmacol201168361962921120482
   PubMed Web of Science ®Google Scholar
• WeissRHLinPYKidney cancer: identification of novel targets for therapyKidney Int200669222423216408110
   PubMed Web of Science ®Google Scholar
• WuCCLiuYChenJCYP4F isoform expression and 20-HETE synthesis in prostate cancer cells are regulated by androgen and contribute to growth [abstract]Cancer Res2012728 Suppl 1LB-160
   Web of Science ®Google Scholar
• ArunBGossPThe role of COX-2 inhibition in breast cancer treatment and preventionSemin Oncol2004312 Suppl 7222915179621
   PubMed Web of Science ®Google Scholar
• BadawiAFThe role of prostaglandin synthesis in prostate cancerBJU Int200085445146210691825
   PubMed Web of Science ®Google Scholar
• GuptaRADuBoisRNTranslational studies on Cox-2 inhibitors in the prevention and treatment of colon cancerAnn N Y Acad Sci200091019620410911914
   PubMed Web of Science ®Google Scholar
• MyersCEGhoshJLipoxygenase inhibition in prostate cancerEur Urol1999355–639539810325495
   PubMed Web of Science ®Google Scholar
• SorokinAEicosanoids and resistance of cancer cells to chemotherapeutic agentsBonavidaBSensitization of Cancer Cells for Chemo/Immuno/Radio-therapyLos Angeles, CAHumana Press2008133156
   Google Scholar
• KhanMFraserACox-2 inhibitors and the risk of cardiovascular thrombotic eventsIr Med J2012105411912122708229
   PubMedGoogle Scholar
• Garcia RodriguezLACea-SorianoLTacconelliSPatrignaniPCoxibs: pharmacology, toxicity and effcacy in cancer clinical trialsRecent Results Cancer Res2013191679322893200
   PubMedGoogle Scholar
• GibsonGGComparative aspects of the mammalian cytochrome P450 IV gene familyXenobiotica19891910112311482683413
   PubMed Web of Science ®Google Scholar
• McGiffJCCarrollMACytochrome P450-dependent arachidonate metabolites, renal function and blood pressure regulationAdv Prostaglandin Thromboxane Leukot Res199121B6756821847570
   PubMedGoogle Scholar
• MiyataNRomanRJRole of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular systemJ Smooth Muscle Res200541417519316258232
   PubMedGoogle Scholar